We are pleased to announce a call for research projects under the HRCI HRB Joint Funding Scheme 2022 to the value of €100,000 over two years. This call is made possible thanks to the kind support of GSK through an unrestricted grant.
The scheme involves a detailed application and international peer review process. To facilitate this our application process is in two parts:
I. Pre-application/letter of intent – to be submitted by Thursday 21st October 2021 at 17.00
II. Full application – to be submitted by Friday 17th December 2021 at 17.00
Please note invitations to submit a full application in Stage II will be subject to review of Stage I Expressions of Interest by the ITS Research Committee.
Full details and HRCI HRB Instructions to Applicants are linked below. (Please note the HRCI HRB Instructions to Applicants 2022 contains details regarding maximum funding levels and suggested timelines for the scheme in general. Please refer to the award amount, grant duration and deadlines detailed above which are specific to the ITS call).
The ITS Call for Research Proposals 2022 document can be found HERE.
The HRCI HRB 2022 Instructions to Applicants document can be found HERE.
Patient and public involvement (PPI) is of central importance in the scheme. Contact details for PPI Ignite programmes in Irish universities are provided in the following table as a helpful resource – HERE.
Please don’t hesitate to contact ITS if you require further information, by email email@example.com or telephone 01 5677 201.